Disease-modifying therapies for multiple sclerosis

What you need to know: Disease-modifying therapies (DMTs) early in the course of active relapsing multiple sclerosis can prevent relapses, new brain and spinal cord lesions, and worsening neurological disability; Some DMTs are associated with potentially serious adverse reactions, and careful monito...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	BMJ (Online) Ročník 363; s. k4674
Hlavní autoři:	De Angelis, Floriana, John, Nevin A, Brownlee, Wallace J
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England BMJ Publishing Group LTD 27.11.2018
Témata:	Blood pressure Case reports Clinical decision making Clinical trials Copolymer 1 Cost analysis Creatinine Decision making Drug dosages Drug therapy Echocardiography EKG Evidence-based medicine Hepatitis B HIV Human immunodeficiency virus Injection Interferon Leukoencephalopathy Magnetic resonance imaging Monoclonal antibodies Multiple sclerosis Neurology Patient care planning Progressive multifocal leukoencephalopathy Thrombocytopenic purpura Thyroid Tuberculosis Urea Varicella United Kingdom > UK
ISSN:	0959-8138, 1756-1833, 1756-1833
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!